跳至主要内容
临床试验/NCT00718276
NCT00718276已完成1 期

Pharmacokinetic Study in Healthy Postmenopausal Women to Compare Supplementation of Vitamin D3 to 25(OH)D

University of Zurich1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
35
试验地点
1
主要终点
serum 25(OH)D levels

研究概览

简要总结

We compare the effect of HyD (25-hydroxyvitamin D) and vitamin D3 in their effect on 25-hydroxyvitamin D plasma levels over a course of 4 month. This is a pharmacokinetic study including 35 postmenopausal women.

  • Trial with medicinal product

详细描述

We include postmenopausal women age 50 to 75, race/ethnicity: Caucasian, serum 25(OH)D at baseline between 20 to 60 nmol/l, body mass index: < 30 kg/m2

to compare 25(OH)D and vitamin D3 in equimolar doses over a 4 month pharmacokinetic trial. The dosing arms are daily, weekly, and bolus

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

1

Active Comparator

25(OH)D

干预措施: 25(OH)D (Drug)

2

Active Comparator

vitamin D3

干预措施: vitamin D3 (Dietary Supplement)

结局指标

主要结局

serum 25(OH)D levels

时间窗: repeated assessments over 4 months

次要结局

  • muscle strength, blood pressure, blood glucose, bone markers(repeated assessments over 4 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验